The healthcare sector has witnessed significant innovation over the past several decades, delivering solutions to improve the welfare of patients worldwide. Conventional exposures to healthcare have tended to focus on pharmaceutical research, while ignoring the role of technology in revolutionizing the management and delivery of healthcare. The PureFunds ETFx HealthTech ETF: IMED concentrates on three technology-driven facets of the expanding healthcare field, namely Healthcare Informatics, Medical Instruments and Medical Devices. Together, these market segments aim for a more informed, technology-focused standard of care, coupling improved patient outcomes with service cost compression.
The Center for Medicare and Medicaid Services estimates that the healthcare sector will reach 20% of U.S. Gross Domestic Product by 2020.2 IMED provides an exposure to innovation-centric market segments in this growing and increasingly important sector.
The PureFunds ETFx HealthTech ETF: IMED, was created to provide the market with a transparent vehicle to invest in the growing intersection of the technology and healthcare industries.
The Fund seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the ETFx HealthTech Index.
2 Sean P. Keehan, Gigi A. Cuckler, Andrea M. Sisko et al., "National Heath Expenditure Projections, 2014-24: Spending Growth Faster than Recent Trends," Health Affairs 34, no. 11 (November 2015): 1407-17, http://content.healthaffairs.org.
AS OF 03/24/2017
|Net Asset Value||$25.72||Closing Price||$24.80|
|Daily Change $||$0.14||Daily Change $||$0.00|
|Daily Change %||0.55%||Closing Price||0.00%|
AS OF 02/28/2017
|1 MONTH||3 MONTH||6 MONTH||1 YEAR||QTD||YTD||SINCE
|Market Value %||5.32%||7.52%||2.09%||-||-||8.09%||1.93|
|QUARTER END AS OF 12/31/2016|
|Market Value %||-0.52%||-8.09%||-||-||-||-||-5.70|
Performance data quoted represents past performance and does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance of the Funds may be lower or higher than the performance quoted. All performance is historical and includes reinvestment of dividends and capital gains. Performance data current to the most recent month end may be obtained by calling 877-756-PURE.
AS OF 03/24/2017
|TICKER||SHARE HELD||MARKET VALUE USD|
|2||GRIFOLS SA||2.01||GRF SM||1,080||$25,820|
|5||ALLSCRIPTS HEALTHCARE SOLUTNS COM||1.93||MDRX||2,076||$24,870|
|7||CHARLES RIV LABS INTL INC||1.91||CRL||279||$24,583|
|8||SYSMEX CORP||1.91||6869 JP||400||$24,533|
|10||WRIGHT MED GROUP N V||1.91||WMGI||789||$24,506|
Fund holdings and sector allocations are subject to change at any time and should not be considered recommendations to buy or sell any security.
The ETFx HealthTech Index is designed to reflect the performance of companies involved in the healthcare technology industry, including companies that provide three technology-driven segments affecting the allocation, delivery and management of healthcare services and products through companies engaged in Healthcare Informatics, Medical Instruments and Medical Appliances. The stocks are screened for liquidity and weighted according to HTXRI's methodology guide. The stocks are screened for liquidity and weighted according to modified equal weight methodology. The Index was created and is maintained by ETFx Investment Partners, LLC. An investment cannot be made directly in an index.